<?xml version="1.0" encoding="UTF-8"?>
<p>After the S1 subunit attaches to the cellular receptors, the virus enters the cell through clathrin-mediated endocytosis and is then transported to the early endosomes (
 <xref rid="B48" ref-type="bibr">Inoue et al., 2007</xref>). From this point forward, the transmembrane protease serine 2 (TMPRSS2) cleaves the SARS-CoV-2 S protein for a second time and facilitates cell entry and the fusion between the endosomal membrane and the viral S2 sequence (
 <xref rid="B44" ref-type="bibr">Hoffmann et al., 2020b</xref>). Consequently, the inhibition of TMPRSS2 could prevent SARS-CoV-2 cellular entry and could play a potential therapeutic role as has been already shown in other viral respiratory syndromes and experimental models (
 <xref rid="B53" ref-type="bibr">Kawase et al., 2012</xref>; 
 <xref rid="B109" ref-type="bibr">Yamamoto et al., 2016</xref>; 
 <xref rid="B44" ref-type="bibr">Hoffmann et al., 2020b</xref>).
</p>
